Skip to main content

ASX Announcements

 
Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013
DateTitle 
09/17/13Removal from Official List at close 17/09/2013Printer Friendly Version
09/17/13ASX Appendix 3B - Options ExercisePrinter Friendly Version
09/17/13ASX Appendix 3B - Options GrantPrinter Friendly Version
09/10/13Suspension from Official Quotation - Close of trading 10/09Printer Friendly Version
09/09/13Options Exercise - ASX Appendix 3BPrinter Friendly Version
09/09/13Change of Director's Interest NoticePrinter Friendly Version
08/28/13US FDA Grants HeartWare Full Approval for Protocol to Supplemental Patient Cohort in Detination Therapy TrialPrinter Friendly Version
08/23/13Options Exercise - ASX Appendix 3BPrinter Friendly Version
08/12/13Appendix 4D and Half Year Financial StatementPrinter Friendly Version
08/08/13Reports 2013 Q2 Rev of US$50.8M vs US$29.1M in Q2 2012Printer Friendly Version
08/08/13Options Exercise - ASX Appendix 3BPrinter Friendly Version
08/08/13Change of Director's Interest NoticePrinter Friendly Version
08/02/13Change of Director's Interest NoticePrinter Friendly Version
08/01/13Change of Director's Interest NoticePrinter Friendly Version
07/30/13Options Exercise - ASX Appendix 3BPrinter Friendly Version
07/19/13Notice of Second Quarter Financial Results CallPrinter Friendly Version
07/16/13ASX Appendix 3B - Options Vesting, Exercise and CancellationPrinter Friendly Version
07/09/13Options Exercise - ASX Appendix 3BPrinter Friendly Version
07/03/13Change of Director's Interest NoticePrinter Friendly Version
07/03/13ASX Appendix 3B - Options Vesting, Exercise and CancellationPrinter Friendly Version
06/26/13ASX Appendix 3B - Options Exercise and CancellationPrinter Friendly Version
06/18/13ASX Appendix 3B - Options Exercise and CancellationPrinter Friendly Version
06/18/13HeartWare Receives Conditional Approval From FDA to Enroll Supplemental Patient Cohort in Destination Therapy Trial Printer Friendly Version
06/12/13HeartWare International Announces Intention To Delist From Australian Securities Exchange (ASX)Printer Friendly Version
06/11/13Change of Director's Interest NoticePrinter Friendly Version
06/06/13Change of Director's Interest NoticePrinter Friendly Version
06/06/13HeartWare Presentation At The Goldman Sachs 34th Annual Global Healthcare Conference To Be Webcast Printer Friendly Version
06/04/13Change of Director's Interest NoticesPrinter Friendly Version
06/04/13ASX Appendix 3B - Options Vesting, Exercise and CancellationPrinter Friendly Version
05/31/13Change of Director's Interest NoticePrinter Friendly Version
05/31/13Change of Director's Interest NoticePrinter Friendly Version
05/31/13Change of Director's Interest NoticePrinter Friendly Version
05/31/13Options Exercise - ASX Appendix 3BPrinter Friendly Version
05/30/13ASX Appendix 3B - Grant of OptionsPrinter Friendly Version
05/22/13Annual General Meeting ResultsPrinter Friendly Version
05/22/13Annual General Meeting/Chairman's AddressPrinter Friendly Version
05/21/13ASX Appendix 3B - Options Vesting and ExercisePrinter Friendly Version
05/20/13Change of Director's Interest NoticesPrinter Friendly Version
05/17/13HeartWare to Webcast Presentation at UBS Global Healthcare ConferencePrinter Friendly Version
05/10/13ASX Appendix 3B - Options vesting and exercisePrinter Friendly Version
05/07/13First Quarter 2013 Financial ResultsPrinter Friendly Version
04/30/13Reports 2013 Q1 Rev of US$49.2M vs US$26.4M in Q1 2012Printer Friendly Version
04/22/13ASX Appendix 3B - Options Vesting, Exercise and CancellationPrinter Friendly Version
04/16/13Notice of Annual General MeetingPrinter Friendly Version
04/02/13ASX Appendix 3B - Options ExercisePrinter Friendly Version
03/27/13ASX Appendix 3B - Options Vesting and ExercisePrinter Friendly Version
03/21/13Change of Director's Interest NoticePrinter Friendly Version
03/19/13HeartWare International, Inc. Announces Closing of Public Offering of Common StockPrinter Friendly Version
03/19/13Options Exercise - ASX Appendix 3BPrinter Friendly Version
03/19/13Capital Raising - ASX Appendix 3B AllotmentPrinter Friendly Version
03/19/13Capital Raising - Cleansing NoticePrinter Friendly Version
03/15/13ASX Appendix 3B - Options ExercisePrinter Friendly Version
03/15/13Prospectus Supplement for Public Offering of Common StockPrinter Friendly Version
03/14/13Prospectus for Public Offering of HeartWare Common StockPrinter Friendly Version
03/13/13Pricing of Public Offering of Common StockPrinter Friendly Version
03/12/13HeartWare Announces Public Offering of Common StockPrinter Friendly Version
03/11/13ASX Appendix 3B - Grant and Cancellation of OptionsPrinter Friendly Version
03/11/13ASX Appendix 3B - Options GrantPrinter Friendly Version
03/07/13HeartWare to Webcast Presentation at Barclays Capital GlobalPrinter Friendly Version
03/01/13HeartWare to Webcast Presentation at Raymond James ConferencePrinter Friendly Version
02/28/13Annual Report for 2012 and ASX Appendix 4EPrinter Friendly Version
02/28/13Reports 2012 Revenue of US$110.9M vs US$82.8M in 2011Printer Friendly Version
02/19/13Notice of Fourth Quarter Financial Results CallPrinter Friendly Version
02/18/13Grant of Incentive Equity - ASX Appendix 3BPrinter Friendly Version
02/11/13HeartWare to webcast presentation at Leerink Swann Global Healthcare Conference to be webcastPrinter Friendly Version
02/11/13HeartWare Initiates Voluntary Field Correction Advising InspPrinter Friendly Version
01/23/13Amended Change of Director's Interest NoticePrinter Friendly Version
01/22/13Change of Director's Interest NoticePrinter Friendly Version
01/16/13ASX Appendix 3B Printer Friendly Version
01/10/13ASX Appendix 3B - Grant and Cancellation of OptionsPrinter Friendly Version
01/08/13HeartWare Announces Preliminary Q4 2012 Revenues of US$32MilPrinter Friendly Version
01/04/13Amended Change of Director's Interest NoticePrinter Friendly Version
01/04/13HeartWare to Webcast Presentation at JP Morgan Healthcare CoPrinter Friendly Version
01/02/13ASX Appendix 3B - Options Exercise and VestingPrinter Friendly Version
01/02/13Change of Director's Interest NoticePrinter Friendly Version
12/21/12ASX Appendix 3B - Options ExercisePrinter Friendly Version
12/21/12Change of Director's Interest NoticePrinter Friendly Version
12/17/12Change of Director's Interest NoticePrinter Friendly Version
12/12/12Options Exercise and Vesting - ASX Appendix 3BPrinter Friendly Version
12/06/12HeartWare to Webcast Presentation at Oppenheimer HealthcarePrinter Friendly Version
12/06/12Change of Director's Interest NoticePrinter Friendly Version
12/06/12ASX Appendix 3B - Options Exercise and CancellationPrinter Friendly Version
11/27/12Options Vesting, Exercise and Expiration - ASX Appendix 3BPrinter Friendly Version
11/27/12Change of Director's Interest NoticePrinter Friendly Version
11/21/12HeartWare Receives U.S. FDA Approval For HVAD PumpPrinter Friendly Version
11/20/12HeartWare to Webcast Presentation at Piper Jaffray HealthcarePrinter Friendly Version
11/16/12Supplemental Financial Information for Q1 2012Printer Friendly Version
11/12/12HeartWare to Webcast Presentation at Lazard Healthcare ConferencePrinter Friendly Version
11/12/12Third Quarter 2012 Financial ResultsPrinter Friendly Version
11/12/12Reports 2012 Q3 Rev of US$ 22.9 M vs. US$ 21.3 M in 2011 Q3Printer Friendly Version
11/02/12Notice of Third Quarter Financial Results CallPrinter Friendly Version
10/23/12Option Exercise - ASX Appendix 3BPrinter Friendly Version
10/16/12HeartWare to Withdraw Participation in Pilot Study Revive-ItPrinter Friendly Version
09/28/12ASX Appendix 3B - Options Exercise and Options CancellationPrinter Friendly Version
09/26/12ASX Appendix 3B - Options GrantPrinter Friendly Version
09/24/12ASX Appendix 3B - Options ExercisePrinter Friendly Version
09/24/12Change of Director's Interest NoticePrinter Friendly Version
09/17/12HeartWare to Webcast Presentation at UBS Global Life SciencePrinter Friendly Version
09/03/12Options Exercise - ASX Appendix 3BPrinter Friendly Version
09/03/12Change of Director's Interest NoticePrinter Friendly Version
08/28/12Change of Director's Interest NoticePrinter Friendly Version
08/22/12Change of Director's Interest NoticePrinter Friendly Version
08/10/12HeartWare to Webcast Presentation at Wedbush PacGrow LifesciencesPrinter Friendly Version
08/09/12Appendix 4D and Half Year Financial StatementPrinter Friendly Version
08/08/12Reports 2012 Q2 Rev of US$29.1 M vs US$20.4 M in 2011 Q2Printer Friendly Version
08/08/12ASX Appendix 3B - Consideration for World Heart AcquisitionPrinter Friendly Version
08/07/12Change of Director's Interest NoticePrinter Friendly Version
08/07/12ASX Appendix 3B - Options ExercisePrinter Friendly Version
08/03/12HeartWare Completes Acquisition of World Heart CorpPrinter Friendly Version
07/31/12Notice of Second Quarter Financial Results CallPrinter Friendly Version
07/20/12Option Exercise - ASX Appendix 3BPrinter Friendly Version
07/19/12Change of Director's Interest NoticePrinter Friendly Version
07/17/12Change of Director's Interest NoticePrinter Friendly Version
07/10/12HeartWare Names Peter McAree Chief Financial OfficerPrinter Friendly Version
07/06/12ASX Appendix 3B - Options Exercise and ForfeiturePrinter Friendly Version
07/06/12Change of Director's Interest NoticePrinter Friendly Version
07/06/12Change of Director's Interest NoticePrinter Friendly Version
06/27/12ASX Appendix 3B - Options ExercisePrinter Friendly Version
06/20/12Change of Director's Interest NoticePrinter Friendly Version
06/19/12Option Exercise - ASX Appendix 3BPrinter Friendly Version
06/15/12Change of Director`s Interest NoticePrinter Friendly Version
06/15/12ASX Appendix 3B - Options ExercisePrinter Friendly Version
06/13/12HeartWare Names New Company SecretaryPrinter Friendly Version
06/13/12Grant of Incentive Equity - ASX Appendix 3BPrinter Friendly Version
06/12/12Change of Director`s Interest NoticePrinter Friendly Version
06/07/12ASX Appendix 3B - Options Exercise and ForfeiturePrinter Friendly Version
06/06/12ASX Appendix 3Z - Final Director`s Interest NoticePrinter Friendly Version
06/06/12Change of Director`s Interest x 8Printer Friendly Version
06/01/12Annual General Meeting ResultsPrinter Friendly Version
06/01/12Annual General Meeting MaterialsPrinter Friendly Version
05/29/12Change of Director`s Interest NoticePrinter Friendly Version
05/25/12ASX Appendix 3B - Options Exercise, Vesting and CancellationPrinter Friendly Version
05/24/12HeartWare Announces Publication of Data from U.S. Bridge to Transplant Clinical TrialPrinter Friendly Version
05/24/12HeartWare Receives CE Mark Addendum For Label ExpansionPrinter Friendly Version
05/23/12Change of Director`s Interest NoticePrinter Friendly Version
05/22/12Change of Director`s Interest NoticePrinter Friendly Version
05/22/12Change of Director`s InterestPrinter Friendly Version
05/22/12Change of Director`s Interest NoticePrinter Friendly Version
05/15/12Change of Director`s Interest NoticePrinter Friendly Version
05/15/12Change of Director`s Interest x 7Printer Friendly Version
05/11/12Reports 2012 Q1 Rev of US$26.3 M vs US$18.0M in Q1 of 2011Printer Friendly Version
05/08/12HeartWare to Webcast Presentation at Bank of America HealthPrinter Friendly Version
05/04/12Notice of First Quarter Financial Results CallPrinter Friendly Version
05/01/12Option Exercise - ASX Appendix 3BPrinter Friendly Version
05/01/12Change of Director`s Interest NoticePrinter Friendly Version
05/01/12Change of Director`s Interest NoticePrinter Friendly Version
04/30/12Notice of Annual General MeetingPrinter Friendly Version
04/26/12HeartWare Receives Favorable US FDA Panel VotePrinter Friendly Version
04/03/12ASX Appendix 3B - Options Vesting, Exercise and CancellationPrinter Friendly Version
03/30/12HeartWare Enters Agreement to Acquire WorldHeart for US$8MPrinter Friendly Version
03/26/12ASX Appendix 3B - Options Grant and CancellationPrinter Friendly Version
03/19/12ASX Appendix 3B - Options vesting, exercise and cancellationPrinter Friendly Version
03/19/12HeartWare Receives New CAP Allotment from FDA for Bridge toPrinter Friendly Version
03/14/12Change of Director`s Interest NoticePrinter Friendly Version
03/07/12Change of Director`s Interest NoticePrinter Friendly Version
03/07/12HeartWare to Webcast Presentation at Barclays Global HealthcPrinter Friendly Version
03/06/12Initial Director`s Interest NoticePrinter Friendly Version
03/06/12HeartWare Presentation At The Barclays Capital 2012 Global Healthcare Conference To Be WebcastPrinter Friendly Version
03/02/12Change of Director`s Interest NoticePrinter Friendly Version
03/02/12Change of Director`s Interest NoticePrinter Friendly Version
02/28/12Annual Report for 2011 and ASX Appendix 4EPrinter Friendly Version
02/27/12Change of Director`s Interest NoticePrinter Friendly Version
02/20/12Change of Director`s Interest NoticePrinter Friendly Version
02/17/12Reports Q4 Rev of US$23.1M and Annual 2011 Rev of US$82.8MPrinter Friendly Version
02/15/12HeartWare Announces Date for FDA Advisory Committee PanelPrinter Friendly Version
02/07/12Notice of Fourth Quarter Financial Results CallPrinter Friendly Version
02/02/12Change of Director`s Interest NoticePrinter Friendly Version
01/10/12HeartWare and Dualis Announce Development AgreementPrinter Friendly Version
01/10/12Q4 2011 Preliminary Revenue and JPM ConferencePrinter Friendly Version
01/09/12Change of Director`s Interest NoticePrinter Friendly Version
12/28/11Grant of Incentive Equity - ASX Appendix 3BPrinter Friendly Version
12/28/11ASX Appendix 3B - Options ExercisePrinter Friendly Version
12/28/11Change of Director`s Interest NoticePrinter Friendly Version
12/15/11Option Exercise - ASX Appendix 3BPrinter Friendly Version
12/15/11Change of Director`s Interest NoticePrinter Friendly Version
12/12/11HeartWare to Present at Oppenheimer Healthcare ConferencePrinter Friendly Version
12/06/11Appendix 3B - Options ExercisePrinter Friendly Version
12/06/11Change of Director`s Interest NoticePrinter Friendly Version
12/05/11Amended Change of Director`s Interest NoticePrinter Friendly Version
11/25/11ASX Appendix 3B - Options ExercisePrinter Friendly Version
11/24/11HeartWare to Present at Piper Jaffray Health Care ConferencePrinter Friendly Version
11/18/11Change of Director`s Interest NoticePrinter Friendly Version
11/14/11ASX Appendix 3B - Options ExercisePrinter Friendly Version
11/11/11HeartWare to Present at Lazard Capital Markets Healthcare CoPrinter Friendly Version
11/04/11Third Quarter 2011 Financial ResultsPrinter Friendly Version
10/28/11HeartWare Announces Third Quarter Revenues of US$21.3 MPrinter Friendly Version
10/28/11HeartWare Announces Planned Departure of CFOPrinter Friendly Version
10/24/11Notice of Third Quarter Financial Results CallPrinter Friendly Version
10/20/11Grant of Incentive Equity - ASX Appendix 3BPrinter Friendly Version
10/10/11Change of Director`s Interest NoticePrinter Friendly Version
10/03/11Presentation of Clinical Update for BTT and CAP at EACTSPrinter Friendly Version
10/03/11HeartWare Announces Updated Clinical Data Presented at EACTSPrinter Friendly Version
09/29/11HeartWare to Present Clinical Update at 25th EACTS in LisbonPrinter Friendly Version
09/22/11ASX Appendix 3B - Options Exercise and VestingPrinter Friendly Version
09/21/11Change of Director`s Interest NoticePrinter Friendly Version
09/20/11HeartWare to Present at Lazard Capital Circulatory Assist CoPrinter Friendly Version
09/15/11HeartWare to Present at UBS Global Life Sciences ConferencePrinter Friendly Version
09/14/11Change of Director`s Interest NoticePrinter Friendly Version
09/12/11Preclinical Data for Next Generation MVAD Pump PresentedPrinter Friendly Version
09/12/11Slide Presentation of MVAD Preclinical Data at ISRBPPrinter Friendly Version
09/12/11Change of Director`s Interest NoticePrinter Friendly Version
09/08/11Change of Director`s Interest NoticePrinter Friendly Version
08/26/11Change of Director`s Interest NoticePrinter Friendly Version
08/24/11Options Grant - ASX Appendix 3BPrinter Friendly Version
08/24/11ASX Appendix 3B - Options ExercisePrinter Friendly Version
08/15/11HeartWare to Present at Wedbush Securities 2011 Health CarePrinter Friendly Version
08/09/11HeartWare to Present at Canaccord Genuity 31st Annual GrowthPrinter Friendly Version
08/08/11Appendix 4D and Half Year Financial StatementPrinter Friendly Version
08/08/11ASX Appendix 3B - Option Exercise and VestingPrinter Friendly Version
08/05/11Reports Second Quarter 2011 Revenues of US$20.4 MillionPrinter Friendly Version
08/03/11Change of Director`s Interest NoticePrinter Friendly Version
07/28/11Second Quarter Financial Results CallPrinter Friendly Version
06/28/11Reimbursement Approval in FrancePrinter Friendly Version
06/28/11Initiation of pre-arranged trading planPrinter Friendly Version
06/28/11Options Exercise - ASX Appendix 3BPrinter Friendly Version
06/28/11ASX Appendix 3B - Option GrantPrinter Friendly Version
06/28/11Change of Director`s Interest NoticePrinter Friendly Version
06/23/11Webcast slides (with clinical update) from Wells Fargo 2011Printer Friendly Version
06/17/11HeartWare to present at Wells Fargo 2011 Healthcare ConferencePrinter Friendly Version
05/27/11ASX Appendix 3B - Option Exercise Printer Friendly Version
05/23/11Change of Director`s Interest Notice Printer Friendly Version
05/20/11Change of Director`s Interest Notice Printer Friendly Version
05/20/11Change of Director`s Interest Notice Printer Friendly Version
05/17/11Change of Director`s Interest NoticePrinter Friendly Version
05/17/11Grant of Incentive Equity - Appendix 3B Printer Friendly Version
05/13/11Annual General Meeting ResultsPrinter Friendly Version
05/12/11Annual General Meeting MaterialsPrinter Friendly Version
05/09/11HeartWare to Present at Bank of America Merrill Lynch HealthPrinter Friendly Version
05/09/11ASX Appendix 3B - Option Exercise and VestingPrinter Friendly Version
05/09/11First Quarter 2011 Financial ResultsPrinter Friendly Version
05/09/11Change of Director`s InterestPrinter Friendly Version
05/06/11Reports First Quarter 2011 Revenues of US$18 MillionPrinter Friendly Version
04/27/11First Quarter Financial Results CallPrinter Friendly Version
04/27/11HeartWare Supplemental Addendum to CE Mark Accepted by BSIPrinter Friendly Version
04/18/11Presentation of BTT and CAP data at ISHLT 2011Printer Friendly Version
04/18/11HeartWare BTT and CAP data presented at ISHLT 2011Printer Friendly Version
04/13/11Announces ISHLT presentations, 1,000 global implantsPrinter Friendly Version
04/11/11Notice of Annual General MeetingPrinter Friendly Version
03/25/11HeartWare receives approval from TGA in AustraliaPrinter Friendly Version
03/18/11U.S. FDA accepts HeartWare PMA filing for reviewPrinter Friendly Version
03/17/11Option Exercise - ASX Appendix 3BPrinter Friendly Version
03/09/11Exercise of Stock Options - ASX Appendix 3BPrinter Friendly Version
03/03/11Option Grant - ASX Appendix 3BPrinter Friendly Version
03/01/11Change of Director`s Interest NoticePrinter Friendly Version
02/28/11Annual Report for 2010 and ASX Appendix 4EPrinter Friendly Version
02/16/11Fourth Quarter Earnings Release CallPrinter Friendly Version
01/28/11Amended Change of Director`s Interest NoticePrinter Friendly Version
01/27/11Option Exercise - ASX Appendix 3BPrinter Friendly Version
01/27/11Change of Director's Interest NoticePrinter Friendly Version
01/25/11HeartWare Named to REVIVE IT Heart Failure StudyPrinter Friendly Version
01/24/11FDA Grants HeartWare 94-Patient Allotment for BTT CAPPrinter Friendly Version
01/18/11Option Exercise - ASX Appendix 3BPrinter Friendly Version
01/11/11Q4 2010 Preliminary Revenue and JPM Conference Printer Friendly Version
01/06/11Option Exercise - ASX Appendix 3B Printer Friendly Version
01/05/11HeartWare to present at JP Morgan Healthcare Conference Printer Friendly Version
12/29/10HeartWare Submits PMA to FDA for Bridge-to-TransplantPrinter Friendly Version
12/23/10Change of Director`s NoticePrinter Friendly Version
12/23/10Annual Employee Equity Allocation / Appendix 3BPrinter Friendly Version
12/21/10HeartWare Insider Trading PolicyPrinter Friendly Version
12/16/10Completion of Concurrent Public OfferingsPrinter Friendly Version
12/16/10ASX Appendix 3B - HeartWare Converible NotesPrinter Friendly Version
12/16/10Change in Director's Interest NoticePrinter Friendly Version
12/16/10Prospectus Public Offering of Common Stock and Convertible NPrinter Friendly Version
12/14/10HeartWare Announces Pricing of Concurrent Public OfferingsPrinter Friendly Version
12/09/10HeartWare International, Inc. Announces Concurrent Public Offerings of Convertible Senior Notes and Common StockPrinter Friendly Version
11/24/10Option Exercise - Appendix 3BPrinter Friendly Version
11/19/10 HeartWare to present at annual Piper Jaffray Health ConferencePrinter Friendly Version
11/15/10ADVANCE trial data presentation at AHA 2010Printer Friendly Version
11/15/10HeartWare Bridge-to-Transplant Data AnnouncementPrinter Friendly Version
11/12/10HeartWare to present at Lazard Annual Healthcare ConferencePrinter Friendly Version
11/10/10Clinical Trial Data at AHA, Investor meeting webcastPrinter Friendly Version
11/05/10Third Quarter 2010 Financial StatementsPrinter Friendly Version
11/04/10Third Quarter ResultsPrinter Friendly Version
10/21/10Third Quarter Earnings Release CallPrinter Friendly Version
09/28/10Option Exercise - ASX Appendix 3BPrinter Friendly Version
09/23/10Change of Director`s Interest NoticePrinter Friendly Version
09/06/10Option Exercise - ASX Appendix 3BPrinter Friendly Version
09/06/10FDA Grants HeartWare Second Patient Allotment Under CAPPrinter Friendly Version
08/19/10Option Grant - ASX Appendix 3BPrinter Friendly Version
08/19/10Option Exercise - ASX Appendix 3B Printer Friendly Version
08/12/10HeartWare Study to be Late-Breaker at American Heart Assn.Printer Friendly Version
08/09/10Appendix 4D and Half Year Financial Statements (US GAAP)Printer Friendly Version
08/06/10HeartWare Announces Second Quarter ResultsPrinter Friendly Version
08/05/10HeartWare to Present at Canaccord Growth ConferencePrinter Friendly Version
07/30/10HeartWare to Present at Wedbush Best Ideas ConferencePrinter Friendly Version
07/28/10Second Quarter Earnings Release CallPrinter Friendly Version
07/07/10Amended ASX Appendix 3BsPrinter Friendly Version
07/02/10Option Exercise - ASX Appendix 3BPrinter Friendly Version
07/02/10Option Grant - ASX Appendix 3BPrinter Friendly Version
06/25/10Announces Board SuccessionPrinter Friendly Version
06/18/10HeartWare to present at Wells FargoPrinter Friendly Version
06/18/10Exercise of Options - ASX Appendix 3BPrinter Friendly Version
06/15/10HeartWare To Commence Destination Therapy TrialPrinter Friendly Version
06/07/10Exercise and Cancellation of OptionsPrinter Friendly Version
05/07/10Change of Director`s Interest NoticesPrinter Friendly Version
05/05/10Annual General Meeting ResultsPrinter Friendly Version
05/05/10Grant of Incentive Equity - Appendix 3BPrinter Friendly Version
05/05/10Annual General Meeting MaterialsPrinter Friendly Version
05/05/10Appendix 3BPrinter Friendly Version
05/05/10First Quarter 2010 Financial StatementsPrinter Friendly Version
05/04/10First Quarter ResultsPrinter Friendly Version
05/03/10Appendix 3BPrinter Friendly Version
04/27/10Initiates voluntary repairs and recalls certain controllersPrinter Friendly Version
04/27/10First 100 Patient Commercial and Clinical DataPrinter Friendly Version
04/12/10Heartware to Report Financial Results First Quarter of 2010Printer Friendly Version
04/12/10Notice of Annual General MeetingPrinter Friendly Version
04/08/10FDA Approves Continued Access Protocol for BTTPrinter Friendly Version
03/26/10Amended ASX Appendix 3BPrinter Friendly Version
03/24/10Change of Director`s Interest NoticePrinter Friendly Version
03/24/10Appendix 3B - Exercise of Stock OptionsPrinter Friendly Version
03/05/10HeartWare to Present at Annual Roth Growth ConferencePrinter Friendly Version
03/03/10Grant and Cancellation of Equity - ASX Appendix 3BPrinter Friendly Version
03/03/10Change of Director's Interest NoticePrinter Friendly Version
03/03/10Appendix 3B - Vesting of Preformance RightsPrinter Friendly Version
02/24/10Annual Report for 2009 and ASX Appendix 4EPrinter Friendly Version
02/23/10Reports Q4 Rev. of US$12.2M and Annual Rev. of US$24.2MPrinter Friendly Version
02/23/10Enrollment of US Bridge to Transplant Trial CompletedPrinter Friendly Version
02/09/10Fourth Quarter and Annual Results for 2009 Earnings CallPrinter Friendly Version
02/03/10Completion of US$62 million Capital RaisingPrinter Friendly Version
02/03/10Capital Raising - Cleansing NoticePrinter Friendly Version
02/03/10Capital Raising - ASX Appendix 3B AllotmentPrinter Friendly Version
02/01/10Exercise and Cancellation of OptionsPrinter Friendly Version
01/28/10Pricing of Public Offering of Common StockPrinter Friendly Version
01/27/10Prospectus for Public Offering of HeartWare Common StockPrinter Friendly Version
01/27/10Public Offering of HeartWare Common StockPrinter Friendly Version
01/12/10Shareholder UpdatePrinter Friendly Version
01/04/10Thoratec Loan Facility UpdatePrinter Friendly Version
12/10/09Exercise of Options - Appendix 3BPrinter Friendly Version
12/08/09Change of Director's Interest NoticePrinter Friendly Version
12/02/09Exercise of Expiring Incentive OptionsPrinter Friendly Version
11/24/09HeartWare files IDE for Destination TherapyPrinter Friendly Version
11/23/09Change of Director's Interest NoticePrinter Friendly Version
11/23/09Exercise of (Expiring) OptionsPrinter Friendly Version
11/17/09Change of Director`s Interest NoticesPrinter Friendly Version
11/17/09Exercise of Options - ASX Appendix 3BPrinter Friendly Version
11/10/09Change of Contact Details for HeartWarePrinter Friendly Version
11/09/09CEO Presenting at Investment ConferencesPrinter Friendly Version
11/06/09HeartWare to Present at Upcoming Investment Conferences in NovemberPrinter Friendly Version
11/05/09Revenues of US$7.5M for Quarter Ended 30 September 2009Printer Friendly Version
11/05/09Financial Statements for September 30, 2009Printer Friendly Version
10/29/09Advance Notice of Q3 Earnings CallPrinter Friendly Version
10/27/09Capital Raising Allotment - ASX Appendix 3BPrinter Friendly Version
10/27/09Stockholder Meeting Results - Capital Raising ApprovedPrinter Friendly Version
10/27/09Cleansing Notice for Capital RaisingPrinter Friendly Version
10/06/09FDA Approves Expansion to 40 Sites for US BTT TrialPrinter Friendly Version
10/05/09Exercise of Incentive OptionsPrinter Friendly Version
09/23/09Notice of Special Meeting of Stockholders - Capital RaisingPrinter Friendly Version
09/21/09Annual Employee Equity AllocationPrinter Friendly Version
09/21/09Exercise and Cancellation of OptionsPrinter Friendly Version
09/07/09Option Exercise and CancellationsPrinter Friendly Version
09/02/09Reinstatement to Official QuotationPrinter Friendly Version
09/02/09Half Yearly Report / Accounts and Review ReportPrinter Friendly Version
08/21/09HeartWare Surpasses 50 US ImplantsPrinter Friendly Version
08/18/09Cleansing Notice for US$60 Miliion PlacementPrinter Friendly Version
08/18/09Closes US$60 Million PlacementPrinter Friendly Version
08/17/09ASX Appendix 4D And Half Year Financial Statements (US GAAP)Printer Friendly Version
08/11/09US$55 Million Capital RaisingPrinter Friendly Version
08/03/09Joint Termination of MergerPrinter Friendly Version
07/31/09Change of Directors Interests - Annual Meeting Stock IssuePrinter Friendly Version
07/31/09Issue of Stock Pursuant to Annual Meeting ApprovalPrinter Friendly Version
07/31/09Quarterly Update And ASX Appendix 4CPrinter Friendly Version
07/30/09Annual Meeting ResultsPrinter Friendly Version
07/30/09US FTC to Challenge Thoratec Acquisition of HeartWarePrinter Friendly Version
07/30/09Trading HaltPrinter Friendly Version
07/30/09Annual Meeting MaterialsPrinter Friendly Version
07/29/09Annual Meeting to be WebcastPrinter Friendly Version
07/21/09Change of Interests in Securities for Executive DirectorPrinter Friendly Version
07/06/09Appendix 3B - Vesting of RSUsPrinter Friendly Version
07/02/09Appendix 3BPrinter Friendly Version
06/18/09Appendix 3BPrinter Friendly Version
06/17/09Revised Thoratec Merger DocumentationPrinter Friendly Version
06/12/09Notice of Annual General Meeting/Proxy FormPrinter Friendly Version
05/12/09CEO Presenting at JMP Securities Research ConferencePrinter Friendly Version
05/12/09Quarterly Financial Statements 31 March 2009Printer Friendly Version
05/11/09Thoratec Files Registration StatementPrinter Friendly Version
05/08/09Thoratec Files Registration StatementPrinter Friendly Version
04/30/09Quarterly Update April 2009 and ASX Appendix 4CPrinter Friendly Version
04/24/09European Clinical Data UpdatePrinter Friendly Version
03/31/09First International Sales of HeartWare® Ventricular Assist System and US Clinical Trial Enrolment UpdatePrinter Friendly Version
03/27/09Thoratec and HeartWare Receive Request for Additional Information from US. Federal Trade CommissionPrinter Friendly Version
03/18/09Appendix 3BPrinter Friendly Version
02/27/092008 Annual Financial ReportPrinter Friendly Version
02/27/092008 Preliminary Final ReportPrinter Friendly Version
02/20/09NASDAQ Listing ConfirmationPrinter Friendly Version
02/19/09HeartWare to be Acquired By Thoratec Corporation for US$282Printer Friendly Version
02/18/09Additional Merger DocumentationPrinter Friendly Version
02/16/09HeartWare to be Acquired By Thoratec Corporation for US$282Printer Friendly Version
02/13/09Trading HaltPrinter Friendly Version
02/10/09First Implants at Northwestern MemorialPrinter Friendly Version
02/06/09Co-PI Appointed for US Clinical TrialPrinter Friendly Version
01/30/09Quarterly Report and CEO LetterPrinter Friendly Version
01/30/09CE Mark Approval receivedPrinter Friendly Version
01/13/09J P Morgan Healthcare Conference PresentationPrinter Friendly Version
12/31/08Cancellation of OptionsPrinter Friendly Version
12/17/08Principal Investigator Appointed for US Clinical TrialPrinter Friendly Version
12/05/08Enrollment of International Trial CompletedPrinter Friendly Version
12/04/08NASDAQ Dual Listing FilingPrinter Friendly Version
11/20/08MVAD & HVAD UpdatePrinter Friendly Version
11/20/082nd US Clinical Site Commences ImplantsPrinter Friendly Version
11/18/08CEO Healthcare Conference PresentationsPrinter Friendly Version
11/07/08Initial Directors Interest NoticePrinter Friendly Version
11/05/08HeartWare Group Redomiciliation and Trading of CDIsPrinter Friendly Version
11/03/08Date of Allotment of CDI SecuritiesPrinter Friendly Version
11/03/08Indicative Top 20 HoldersPrinter Friendly Version
11/03/08Admission to the Official ListPrinter Friendly Version
11/03/08Lodgement of Court Orders with ASICPrinter Friendly Version
10/31/08Quarterly Update And ASX Appendix 4CPrinter Friendly Version
10/30/08Federal Court Approval of Schemes of ArrangementPrinter Friendly Version
10/24/08Cleveland Clinic PresentationPrinter Friendly Version
10/22/08Redomiciliation Meeting MaterialsPrinter Friendly Version
10/22/08Redomiciliation Meeting ResultsPrinter Friendly Version
10/20/08Awarded ISO CertificationPrinter Friendly Version
10/15/08Medical Conference PresentationsPrinter Friendly Version
10/03/08Non-Executive Director AppointedPrinter Friendly Version
10/03/08Initial Directors Interest NoticePrinter Friendly Version
09/25/08Cancellation of OptionsPrinter Friendly Version
09/23/08FDA Grants Full IDE Approval in the United StatesPrinter Friendly Version
09/22/08Redomiciliation Documents Dispatched to ShareholdersPrinter Friendly Version
09/17/08Federal Court Approval for Scheme Meetings for RedomiciliationPrinter Friendly Version
09/15/08Change of Directors InterestsPrinter Friendly Version
09/11/08CE Mark SubmissionPrinter Friendly Version
09/08/08Change of Directors InterestPrinter Friendly Version
09/04/08Change of Share RegistryPrinter Friendly Version
09/03/08Cancellation of OptionsPrinter Friendly Version
09/03/08Change of Directors InterestsPrinter Friendly Version
09/03/08Change of Directors InterestsPrinter Friendly Version
08/28/08Change of Directors InterestsPrinter Friendly Version
08/27/08Change of Directors InterestsPrinter Friendly Version
08/26/08Change of Directors InterestsPrinter Friendly Version
08/25/08Change of Directors InterestsPrinter Friendly Version
08/22/08Change of Directors InterestsPrinter Friendly Version
08/21/08First U.S. ImplantPrinter Friendly Version
08/19/08Change of Directors InterestsPrinter Friendly Version
08/14/08Annual Equity AwardPrinter Friendly Version
08/14/08Change of Directors InterestsPrinter Friendly Version
08/13/08Half-Year Financial Report 30 June 2008Printer Friendly Version
08/12/08Canaccord Adams PresentationPrinter Friendly Version
08/12/08Canaccord Adams PresentationPrinter Friendly Version
08/12/08Canaccord Adams PresentationPrinter Friendly Version
08/05/08Proposed Redomiciliation in the United StatesPrinter Friendly Version
08/01/08First IRB Approval in the United StatesPrinter Friendly Version
07/31/08Quarterly Update and Appendix 4CPrinter Friendly Version
07/25/08Redemption of Convertible NotePrinter Friendly Version
07/11/08Change of Directors Interests - PlacementPrinter Friendly Version
07/11/08Grant of Options to Non Executive DirectorPrinter Friendly Version
07/11/08Completion of Placement A$31MPrinter Friendly Version
07/11/08Results of EGMPrinter Friendly Version
07/11/08EGM MaterialsPrinter Friendly Version
06/20/08Cancellation of OptionsPrinter Friendly Version
06/11/08SPP CancelledPrinter Friendly Version
06/04/08Notice of Extraordinary General MeetingPrinter Friendly Version
05/27/08Shareholder Share Purchase Plan UpdatePrinter Friendly Version
05/26/08Preliminary Notice of Meeting - EGMPrinter Friendly Version
05/23/08Private Placement in Excess of A$30 MillionPrinter Friendly Version
05/16/08Operational UpdatePrinter Friendly Version
05/09/082008 Annual General MeetingPrinter Friendly Version
05/09/08Results of Annual General Meeting 2008Printer Friendly Version
05/09/08Grant of Performance RightsPrinter Friendly Version
05/09/08Change of Directors InterestPrinter Friendly Version
05/08/08Change of Directors InterestsPrinter Friendly Version
05/06/08Change of Directors InterestsPrinter Friendly Version
05/05/08FDA grants conditional IDE approvalPrinter Friendly Version
05/02/08Change of Directors InterestPrinter Friendly Version
04/30/08Non-Executive Director AppointedPrinter Friendly Version
04/30/08Quarterly Update And ASX Appendix 4CPrinter Friendly Version
04/29/08Chief Medical Officer AppointePrinter Friendly Version
04/18/08New Manufacturing FacilityPrinter Friendly Version
04/18/082007 Annual ReportPrinter Friendly Version
04/14/08Clinical Data for First 23 PatientsPrinter Friendly Version
04/14/08Clinical Data for First 23 PatientsPrinter Friendly Version
04/09/08Notice of Annual General Meeting 2008Printer Friendly Version
03/26/08Draft Notice of Annual General Meeting 2008Printer Friendly Version
03/26/08Cancellation of Employee Share OptionsPrinter Friendly Version
03/04/0830th Patient - Survival UpdatePrinter Friendly Version
02/29/082007 ASX Appendix 4E - Preliminary Final ReportPrinter Friendly Version
02/29/082007 Annual Financial Report And Directors ReportPrinter Friendly Version
02/29/082007 US Annual Report (US GAAP)Printer Friendly Version
02/06/08Change of Directors InterestPrinter Friendly Version
02/05/08Change of Directors InterestPrinter Friendly Version
01/31/08Quarterly Update & 4CPrinter Friendly Version
01/27/08Incentive Option Terms for Non-Exec.Directors & Inteq LtdPrinter Friendly Version
12/19/07Shareholder UpdatePrinter Friendly Version
12/13/07Appendix 3B - ESOPPrinter Friendly Version
12/04/07Change of Address of Share RegistryPrinter Friendly Version
11/20/07Performance Rights and ESOP GrantPrinter Friendly Version
11/20/07Appendix 3B - ESOPPrinter Friendly Version
11/20/07Appendix 3B - Incentive OptionsPrinter Friendly Version
11/02/07Presentation at ISRBP ConferencePrinter Friendly Version
11/01/07Submission to FDA for Investigational Device Exemption (IDE)Printer Friendly Version
10/31/07Quarterly Update And ASX Appendix 4CPrinter Friendly Version
09/03/07Completion of Enrolment in International Clinical TrialPrinter Friendly Version
08/31/07Interim Financial Report 30 June 2007Printer Friendly Version
08/21/07Change of Directors InterestPrinter Friendly Version
08/15/07US GAAP Financial Statements - Quarter Ended 30 June 2007Printer Friendly Version
08/07/07Participant BulletinPrinter Friendly Version
07/31/07Quarterly Update And ASX Appendix 4CPrinter Friendly Version
07/26/07EGM Presentation MaterialsPrinter Friendly Version
07/26/07Results of EGMPrinter Friendly Version
07/26/07Private Placement CompletePrinter Friendly Version
07/26/07Change of Directors InterestPrinter Friendly Version
07/26/07Grant of Options Under ESOPPrinter Friendly Version
07/26/07Change of Directors InterestPrinter Friendly Version
07/26/07Change of Directors InterestPrinter Friendly Version
07/24/07First Recovery PatientPrinter Friendly Version
07/24/07Share Purchase Plan ClosedPrinter Friendly Version
07/19/07Dual Reporting RequirementsPrinter Friendly Version
07/17/07Updated Registration Statement on Form 10 - US GAAP FinancialsPrinter Friendly Version
07/13/07Clinical Trial Update - July 2007Printer Friendly Version
07/10/07Change of AddressPrinter Friendly Version
07/04/07Change of Directors' InterestPrinter Friendly Version
07/03/07Change of Directors InterestPrinter Friendly Version
06/27/07Notice of EGMPrinter Friendly Version
06/26/07Share Purchase PlanPrinter Friendly Version
06/14/07Private Placement in Excess of $30 MillionPrinter Friendly Version
05/24/07Annual General Meeting ConfirmationPrinter Friendly Version
05/23/07Annual General Meeting MaterialsPrinter Friendly Version
05/23/07Results of Annual General MeetingPrinter Friendly Version
05/01/07HeartWare Moves Towards NASDAQ ListingPrinter Friendly Version
04/30/07Quarterly Update And ASX Appendix 4CPrinter Friendly Version
04/20/07Annual Report & Notice of AGMPrinter Friendly Version
04/20/07Cancellation of ESOP OptionsPrinter Friendly Version
04/11/07First Implant at St Vincent'sPrinter Friendly Version
04/03/07Ethics Committee Approval at St Vincent's HospitalPrinter Friendly Version
04/02/07Fourth Implant Centre OpenedPrinter Friendly Version
03/22/07One Year Anniversary of First ImplantPrinter Friendly Version
03/13/07Shareholder UpdatePrinter Friendly Version
03/13/07CEO PresentationPrinter Friendly Version
02/28/07ASX Appendix 4E 31 December 2006Printer Friendly Version
02/28/072006 Annual Financial Report and Directors' ReportPrinter Friendly Version
01/31/07Quarterly Update & ASX Appendix 4CPrinter Friendly Version
01/18/07End of Restriction PeriodPrinter Friendly Version
01/18/07Appendix 3B - Exercise of ESOP OptionsPrinter Friendly Version
01/10/07First Implant at Hannover Medical CentrePrinter Friendly Version
01/03/07Grant of Options under ESOPPrinter Friendly Version
01/03/07Letter to ShareholdersPrinter Friendly Version
01/03/07Change of Directors InterestPrinter Friendly Version
12/11/06Appointment of Non Executive DirectorPrinter Friendly Version
11/29/06CEO Presentation November 2006Printer Friendly Version
11/29/06Change of Directors InterestsPrinter Friendly Version
11/22/06Executive Appointment & 5th ImplantPrinter Friendly Version
11/20/06Change of Directors InterestPrinter Friendly Version
11/06/06Change of Directors InterestPrinter Friendly Version
10/31/06Quarterly ReportPrinter Friendly Version
10/31/06Appointment of Executive DirectorPrinter Friendly Version
10/31/06Grant of OptionsPrinter Friendly Version
10/23/06First Implant at Royal PerthPrinter Friendly Version
10/23/06ASX Appendix 3BPrinter Friendly Version
10/18/06Change of Directors InterestPrinter Friendly Version
10/11/06Letter to ShareholdersPrinter Friendly Version
10/10/06Change of Directors InterestPrinter Friendly Version
10/10/06Change of Directors InterestPrinter Friendly Version
10/04/06Appendix 3BPrinter Friendly Version
10/03/06Change of Directors InterestPrinter Friendly Version
09/14/06Change of Directors InterestPrinter Friendly Version
09/04/06Appointment of New Chief Executive OfficerPrinter Friendly Version
07/31/062006 Interim Financial ReportPrinter Friendly Version
07/31/06Quarterly Cash Flow June 2006Printer Friendly Version
07/26/06ESOP GrantPrinter Friendly Version
07/07/06German Regulatory ApprovalPrinter Friendly Version
07/06/06Clarification of Option CancellationPrinter Friendly Version
07/05/06ASX Appendix 3BPrinter Friendly Version
06/20/06Change of Directors InterestPrinter Friendly Version
06/19/06Change of Directors InterestPrinter Friendly Version
06/16/06Change of Directors InterestPrinter Friendly Version
06/16/06Closing of HeartWare SPPPrinter Friendly Version
06/15/06Presentation at the Australian Biotechnology ExpoPrinter Friendly Version
06/13/06Change of Directors InterestPrinter Friendly Version
05/23/062006 Annual General Meeting PresentationPrinter Friendly Version
05/23/06Annual General Meeting ResultsPrinter Friendly Version
05/23/06Completion of Capital RaisingPrinter Friendly Version
05/22/06Regulatory Approval in the United KingdomPrinter Friendly Version
05/19/06HeartWare Shareholder Share Purchase PlanPrinter Friendly Version
05/15/06Change of Directors InterestPrinter Friendly Version
05/11/06Change of Directors InterestPrinter Friendly Version
05/10/06$32.5 Million Capital RaisingPrinter Friendly Version
04/28/06Clinical Trial Update - April 2006Printer Friendly Version
04/21/06Chief Operating Officer AppointedPrinter Friendly Version
04/20/06Annual Report 2005 and Notice of Annual General MeetingPrinter Friendly Version
04/20/06ASX Appendix 4C Quarter Ended 31 March 2006Printer Friendly Version
03/27/06Annual Financial Report and Directors Report 31 Dec 2005Printer Friendly Version
03/24/06Clinical Trials CommencePrinter Friendly Version
03/15/06Change of Directors InterestsPrinter Friendly Version
03/08/06TGA ApprovalPrinter Friendly Version
02/28/06ASX Appendix 4EPrinter Friendly Version
01/31/06ASX Appendix 4C 31 December 2005Printer Friendly Version
01/30/06Removal of FORUSPrinter Friendly Version
01/24/06Amended Director InterestsPrinter Friendly Version
01/10/06End of Restriction PeriodPrinter Friendly Version
01/05/06Regulatory ApprovalPrinter Friendly Version
01/03/06Initial Substantial Shareholder NoticePrinter Friendly Version
12/15/05Appendix 3BPrinter Friendly Version
12/01/05Change of Directors InterestPrinter Friendly Version
12/01/05ASX Appendix 3BPrinter Friendly Version
11/10/05Settlement of Patent DisputePrinter Friendly Version
11/02/05Completion of StudiesPrinter Friendly Version
10/19/05Negotiations CommencePrinter Friendly Version
10/19/05Quarterly Cash FlowPrinter Friendly Version
10/11/05Advisory Board GLP ReviewPrinter Friendly Version
09/27/05Change of Directors InterestPrinter Friendly Version
09/09/05New Medical Advisory Board AppointeePrinter Friendly Version
09/06/05Ventracor Litigation AnnouncementPrinter Friendly Version
09/06/05Change of AddressPrinter Friendly Version
08/31/05MVADPrinter Friendly Version
08/16/05CEO PresentationPrinter Friendly Version
08/02/05Defence and Counterclaim to LitigationPrinter Friendly Version
08/01/05GLP UpdatePrinter Friendly Version
07/29/05BIVAD ImplantPrinter Friendly Version
07/25/05Half Year ReportPrinter Friendly Version
07/25/05ASX Appendix 4CPrinter Friendly Version
07/22/05Shareholder UpdatePrinter Friendly Version
07/01/05Change of Directors InterestPrinter Friendly Version
07/01/05Appendix 3BPrinter Friendly Version
05/27/05Change of Director's Interest NoticePrinter Friendly Version
05/23/05Appendix 3B - Exercise of OptionsPrinter Friendly Version
05/03/05New Executive Appointments & Appendix 3BPrinter Friendly Version
03/17/05VCR release re claims on VCR's ASX announcement platformPrinter Friendly Version
03/16/05Shareholder UpdatePrinter Friendly Version
03/10/05Change of Director's Interest NoticePrinter Friendly Version
03/04/05Appointment of Chief Financial OfficerPrinter Friendly Version
03/04/05Change of Director's Interest NoticePrinter Friendly Version
02/22/05Change of Director's Interest NoticePrinter Friendly Version
02/15/05Change of Director's Interest NoticePrinter Friendly Version
02/10/05Granted first European PatentPrinter Friendly Version
02/08/05Change of Director's Interest NoticePrinter Friendly Version
02/08/05Amended Appendix 3X - Initial Director's Interest NoticePrinter Friendly Version
02/07/05Change of Director's Interest Notice x2Printer Friendly Version
02/02/05Change of Director's Interest Notice x2Printer Friendly Version
02/01/05Initial Director's Interest Notice x5Printer Friendly Version
01/28/05Correction to Admission to Official List-Issue Price AmendedPrinter Friendly Version
01/27/05ConstitutionPrinter Friendly Version
01/27/05Appendix 1A - ASX Listing Application & AgreementPrinter Friendly Version
01/27/05Convertible Note TermsPrinter Friendly Version
01/27/05Employee Share Option PlanPrinter Friendly Version
01/27/05Statement of CommitmentsPrinter Friendly Version
01/27/05Top 20 HoldersPrinter Friendly Version
01/27/05Escrow StatementPrinter Friendly Version
01/27/05Distribution SchedulePrinter Friendly Version
01/27/05Company's Letter to Australian Stock ExchangePrinter Friendly Version
01/27/05Pre-Quotation DisclosurePrinter Friendly Version
01/27/05Admission to Official ListPrinter Friendly Version
01/27/05Circular to Participating Organisations - Regulation SPrinter Friendly Version
01/27/05Circular re Commencement of Official QuotationPrinter Friendly Version
01/17/05Disclosure DocumentPrinter Friendly Version
12/17/04ProspectusPrinter Friendly Version